About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02374866

Monitoring Obese Patients : Impact on the Frequency of Monitoring Weight

The literature data show that long-term monitoring has an effect on weight loss, comorbidity and on improving the quality of life. However, there are still no studies on monitoring obese patients afte...

Lead sponsor: University Hospital, Limoges•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Limoges

2 groups of randomized patients will be followed: * The control group will follow the current center: every four months for a year, combined with monitoring by email or regular mail during the year. * The experimental group will be a follow-up every two months for one year HDJ more of the same followed by email or postal mail. Follow by email or mail is identical to the control group, as well as HDJ 12 months.

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\- Age ≥ 18 - ≤ 75 years
•Obesity with a BMI ≥ 35 or ≥ 30 if associated with at least one comorbidity whose support was commenced or continued during the initial hospitalization.
•Patients hospitalized for a period of at least 3 weeks in the Bernard Descottes center and were supported on dietary, psychological, psychomotor and physical education in a therapeutic approach.
•Patients who have signed consent form.
•Patients who never underwent bariatric surgery and bariatric surgery have not seen in the year following their hospitalization in Bernard Descottes Center.
•Patient accepting the constraints of the protocol in case of close monitoring.
•Patients able to travel with their own vehicle to Bernard Descottes Center.
•Affiliate or beneficiary of a social security scheme

Exclusion Criteria

•\- Patients who have hospitalized in Bernard Descottes Center.
•Failure to follow the protocol because of insufficient command of French or concomitant illness.
•Pregnant or breastfeeding.
•Patients under guardianship or under judicial protection.
•Participation to another trial which can impact on patient's experimental disease during all the study, and patients who are in an exclusion period of another trial.

Related studies

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

RECRUITINGPhase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

NCT07595549 · Obesity, Overweight and/or Obesity, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 5, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment96

Start dateMar 2015

Last updatedSep 5, 2016

Condition

Obesity Morbid Obesity Quality of Life

Locations shown

Centre de suivi de l'obésite Bernard Descottes

Saint-Yrieix-la-Perche

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 5, 2016Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions